FDA recall Z-2310-2021

OPTI Medical Systems, Inc · Class II · device

Product

OPTI SARS-CoV-2 RT-PCR Test, REF Numbers: a) 99-57003 b) 99-57004

Reason for recall

The firm identified a precipitation issue which may cause late Ct reactors (a false positive result) with a rate of 5 to 10% for affected vials of RNA Master Mix.

Distribution

Maine, New York, Alabama, Pennsylvania, Florida, Illinois, New Jersey, Connecticut, Georgia, Puerto Rico, Costa Rica, Hong Kong, Philippines, Barbados

Key facts

Status
Ongoing
Initiation date
2021-06-25
Report date
2021-08-25
Voluntary/Mandated
Voluntary: Firm initiated
Location
Roswell, GA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2310-2021